Pharmalink AB Raises SEK 35 Million Through Share Issue
1/4/2012 10:05:08 AM
More...
|
Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT(R) Technology for Nefecon(R) (PL-56) Program
12/13/2011 10:13:24 AM
More...
|
Pharmalink AB Elects Anders Wiklund as Chairman and Appoints Elisabeth Lindner to its Board of Directors
11/14/2011 12:32:45 PM
More...
|
Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
5/20/2010 9:41:47 AM
More...
|
Pharmalink AB Receives Patent for Nefecon(R) Principle
10/26/2009 8:25:18 AM
More...
|
Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)
4/29/2009 11:37:19 AM
More...
|
Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development
4/23/2009 10:17:23 AM
More...
|